Cancer Research UK logo.
SearchDonate
  • Search

A trial comparing blinatumomab with chemotherapy for acute lymphoblastic leukaemia (TOWER)

Overview

Cancer types:

Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Leukaemia

Status:

Results

Phase:

Phase 3

Details

This trial compared blinatumomab with chemotherapy for people who have acute lymphoblastic leukaemia (ALL).

It was for people with ALL that hadn’t responded to treatment or had come back after treatment.

This trial was open for people to join between January 2014 and September 2015. These results were published in 2017 and 2018.

Recruitment start: 3 January 2014

Recruitment end: 4 September 2015

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Adele Fielding

Supported by

Amgen

NIHR Clinical Research Network: Cancer

Last reviewed: 09 Jul 2019

CRUK internal database number: 12064

Help and support